Adrienne M. See

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II).

Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II).

Journal: BMJ open

Published: September 03, 2026

A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.

A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.

Journal: Frontiers in oncology

Published: April 17, 2024

A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms due to Intrathoracic Disease Who are Not Suitable for Radical Chemo-radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial.

A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms due to Intrathoracic Disease Who are Not Suitable for Radical Chemo-radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial.

Journal: Practical radiation oncology

Published: August 31, 2020

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Journal: The Cochrane database of systematic reviews

Published: November 25, 2016

Partial breast irradiation for early breast cancer.

Partial breast irradiation for early breast cancer.

Journal: The Cochrane database of systematic reviews

Published: July 19, 2016

Fraction size in radiation therapy for breast conservation in early breast cancer.

Fraction size in radiation therapy for breast conservation in early breast cancer.

Journal: The Cochrane database of systematic reviews

Published: July 19, 2016

Partial breast irradiation for early breast cancer.

Partial breast irradiation for early breast cancer.

Journal: The Cochrane database of systematic reviews

Published: June 19, 2014

Adjuvant radiotherapy following radical prostatectomy for prostate cancer.

Adjuvant radiotherapy following radical prostatectomy for prostate cancer.

Journal: The Cochrane database of systematic reviews

Published: December 14, 2011

Showing 1-8 of 8

Last Updated: 09/26/2026